NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 113 filers reported holding NATERA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 50 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -83.8% | 50 | -86.1% | 0.00% | -100.0% |
| Q1 2021 | $37,000 | -59.3% | 360 | -60.4% | 0.00% | -57.1% |
| Q4 2020 | $91,000 | +37.9% | 910 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $66,000 | +46.7% | 910 | 0.0% | 0.01% | +50.0% |
| Q2 2020 | $45,000 | -6.2% | 910 | -43.5% | 0.00% | 0.0% |
| Q1 2020 | $48,000 | -11.1% | 1,610 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $54,000 | +5.9% | 1,610 | +3.2% | 0.01% | 0.0% |
| Q3 2019 | $51,000 | +18.6% | 1,560 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $43,000 | +34.4% | 1,560 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $32,000 | +45.5% | 1,560 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $22,000 | -40.5% | 1,560 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $37,000 | +27.6% | 1,560 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $29,000 | +107.1% | 1,560 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $14,000 | 0.0% | 1,560 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $14,000 | – | 1,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |